Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score

Journal of Cardiac Failure

Volumn 22, Issue 11, 2016, Pages 853-858

  AbouEzzeddine, Omar F ^a   Wong, Yee Weng ^b,c   Mentz, Robert J ^b,c   Raza, Sadi S ^d   Nativi Nicolau, Jose ^e   Kociol, Robb D ^f   McNulty, Steven E ^c   Anstrom, Kevin J ^c   Hernandez, Adrian F ^c   Redfield, Margaret M ^a  

^a MAYO CLINIC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Acute heart failure; clinical trials; quality of life

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DYSPNEA; DYSPNEA VISUAL ANALOGUE SCALE; FATIGUE; FEMALE; GLOBAL WELL BEING VISUAL ANALOGUE SCALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWELLING; SYMPTOM ASSESSMENT; URINE VOLUME; VISUAL ANALOG SCALE; WORST SYMPTOM VISUAL ANALOGUE SCALE; ACUTE DISEASE; BLOOD; COMPARATIVE STUDY; COMPLICATION; EDEMA; EVALUATION STUDY; HEART FAILURE; KIDNEY FAILURE; MIDDLE AGED; NONPARAMETRIC TEST; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; BIOMARKERS; DIURETICS; DYSPNEA; EDEMA; FATIGUE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PAIN MEASUREMENT; PROGNOSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 84993881912     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2015.12.015     Document Type: Article

References (12)

1. 1 Yancy, C.W., Jessup, M., Bozkurt, B., Masoudi, F.A., Butler, J., McBride, P.E., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 62 (2013), 147–239.
2. 2 Teerlink, J.R., Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure. Am Heart J 145:2 Suppl (2003), S26–33.
3. 3 Kato, M., Stevenson, L.W., Palardy, M., Campbell, P.M., May, C.W., Lakdawala, N.K., et al. The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy. J Card Fail 18 (2012), 524–533.
4. 4 Chen, H.H., AbouEzzeddine, O.F., Anstrom, K.J., Givertz, M.M., Bart, B.A., Felker, G.M., et al. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail 6 (2013), 1087–1094.
5. 5 Allen, L.A., Metra, M., Milo-Cotter, O., Filippatos, G., Reisin, L.H., Bensimhon, D.R., et al. Improvements in signs and symptoms during hospitalization for acute heart failure follow different patterns and depend on the measurement scales used: an international, prospective registry to evaluate the evolution of measures of disease severity in acute heart failure (MEASURE-AHF). J Card Fail 14 (2008), 777–784.
6. 6 Teerlink, J.R., Cotter, G., Davison, B.A., Felker, G.M., Filippatos, G., Greenberg, B.H., et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381 (2013), 29–39.
7. 7 Mebazaa, A., Pang, P.S., Tavares, M., Collins, S.P., Storrow, A.B., Laribi, S., et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J 31 (2010), 832–841.
8. 8 Bart, B.A., Goldsmith, S.R., Lee, K.L., Givertz, M.M., O'Connor, C.M., Bull, D.A., et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 367 (2012), 2296–2304.
9. 9 Kjellstrom, B., van der Wal, M.H., Old and new tools to assess dyspnea in the hospitalized patient. Curr Heart Fail Rep 10 (2013), 204–211.
10. 10 Jurgens, C.Y., Moser, D.K., Armola, R., Carlson, B., Sethares, K., Riegel, B., Symptom clusters of heart failure. Res Nurs Health 32 (2009), 551–560.
11. 11 Felker, G.M., Lee, K.L., Bull, D.A., Redfield, M.M., Stevenson, L.W., Goldsmith, S.R., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364 (2011), 797–805.
12. 12 Binanay, C., Califf, R.M., Hasselblad, V., O'Connor, C.M., Shah, M.R., Sopko, G., et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294 (2005), 1625–1633.